MHRA
- Local brand name: Eliquis
- Status: approved
🇬🇧 Eliquis in United Kingdom
NICE has issued 4 UK HTA decisions
Marketing authorisation
Health technology assessment
4 decisions from NICE for Eliquis in United Kingdom.
NICE TA275 — ✓ Recommended
- Indication assessed: preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
NICE recommended Eliquis for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation. This decision was made without a Patient Access Scheme or commercial arrangement. No restrictions were placed on the use of Eliquis.
NICE TA341 — ✓ Recommended
- Indication assessed: the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
NICE recommended Eliquis for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism. This decision was made without a Patient Access Scheme or commercial arrangement. The cost-effectiveness of Eliquis was not reported in terms of ICER.
NICE TA245 — ✓ Recommended
- Indication assessed: preventing venous thromboembolism after hip or knee replacement surgery
NICE recommended Eliquis for preventing venous thromboembolism after hip or knee replacement surgery. This decision was made without a Patient Access Scheme or commercial arrangement. The restriction text was not specified.
NICE TA697 — ✓ Recommended
- Indication assessed: reversing anticoagulation from apixaban or rivaroxaban
NICE recommended Eliquis for reversing anticoagulation from apixaban or rivaroxaban in the United Kingdom. This decision was made based on a commercial arrangement and a patient access scheme, which suggests that the cost of the drug was negotiated to be within the National Health Service's budget. There were no restrictions placed on the use of Eliquis for this indication.
Eliquis in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United Kingdom
Frequently asked questions
Is Eliquis approved in United Kingdom?
Yes. MHRA has authorised it.
Who is the marketing authorisation holder for Eliquis in United Kingdom?
Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.
Has Eliquis been assessed by UK health technology agencies?
Yes — 4 UK HTA decisions on record from NICE.